24 scientists and researchers receive awards from Technology Development Group
The awards, up to $150,000 per project, support early stage research that lead to commercialization activities
Stay updated with breaking news from Harvey Herschman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The awards, up to $150,000 per project, support early stage research that lead to commercialization activities
ISB and a collaborative team of researchers looked at hexokinase-2, or HK2, a key enzyme in glucose metabolism. "A set of previous reports from our collaborator Dr. Herschman (co-author of the paper) and others revealed that cancer cells often rely on HK2 to elevate glucose metabolism to fuel their uncontrolled growth, making this enzyme a desirable target for testing," said ISB Assistant Professor Dr. Wei Wei, the lead corresponding author of the paper. Conventional CTC detection methods, as exemplified by the FDA-cleared CellSearch system, normally rely on the use of a family of proteins ...
A Better Way to Find Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients Share Article Institute for Systems Biology researchers and their collaborators have developed a novel method to better detect the circulating tumor cells in Non-Small Cell Lung Cancer patients. The cells circulate in the bloodstream and are a telltale sign of metastases. Assistant Professor Dr. Wei Wei, left, and Bioinformatics Scientists Dr. Xiaowei Yan are pictured at Institute for Systems Biology in 2019. (Scott Eklund / Red Box Pictures) "This approach will be useful in identifying circulating tumor cells...